Inhibrx Biosciences INBX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 79.00 | 8 | -146.51 | -33 | -20.27 | 146 |
| 2025Q3 | 33.68 | 37 | -66.91 | -35 | -18.10 | 177 |
| 2025Q2 | 14.27 | 69 | -35.16 | -29 | -12.60 | 212 |
| 2025Q1 | 13.99 | 94 | -37.99 | -43 | -20.46 | 243 |
| 2024Q4 | 15.40 | 134 | -30.68 | -48 | -23.73 | 181 |
| 2024Q3 | 15.66 | 178 | -22.05 | -44 | -18.24 | 223 |
| 2024Q2 | 14.17 | 219 | 1609.13 | 1,858 | 679.35 | 258 |
| 2024Q1 | 12 | -285.85 | -79 | -26.39 | 289 | |
| 2023Q4 | 44 | -108.15 | -94 | -27.51 | 308 | |
| 2023Q3 | 130 | -52 | -17.68 | 373 | ||
| 2023Q2 | -25 | -47 | -20.16 | 213 | ||
| 2023Q1 | 15 | -133.67 | -49 | -17.96 | 254 | |
| 2022Q4 | 58 | -41 | -17.96 | 291 | ||
| 2022Q3 | -35 | -35 | -19.73 | 165 | ||
| 2022Q2 | -5 | -38 | -21.29 | 193 | ||
| 2022Q1 | 27 | -78.40 | -31 | -20.06 | 161 | |
| 2021Q4 | 52 | -52.59 | -21 | -15.16 | 150 | |
| 2021Q3 | 28 | -56.76 | -21 | -15.18 | 129 | |
| 2021Q2 | 44 | -39.48 | -21 | -15.55 | 142 | |
| 2021Q1 | 61 | -28.35 | -19 | -14.38 | 125 |